Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Neogenomics Inc (NEO)

Neogenomics Inc (NEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
NeoGenomics: Q4 Earnings Snapshot

NeoGenomics: Q4 Earnings Snapshot

NEO : 15.80 (+3.95%)
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

EQNX::TICKER_START (OTCQB:TDSGF),(TSXV:TELO),(NYSE:BMY),(NYSE:TMO),(NASDAQ:NTRA),(NASDAQ:NEO) EQNX::TICKER_END

TDSGF : 0.0829 (+0.36%)
TELO.VN : 0.110 (-8.33%)
BMY : 54.23 (+1.84%)
TMO : 580.74 (+0.24%)
NTRA : 90.96 (+0.55%)
NEO : 15.80 (+3.95%)
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

TDSGF : 0.0829 (+0.36%)
TELO.VN : 0.110 (-8.33%)
BMY : 54.23 (+1.84%)
TMO : 580.74 (+0.24%)
NTRA : 90.96 (+0.55%)
NEO : 15.80 (+3.95%)
Altice USA, PENN Entertainment rise; Hess, NeoGenomics fall, Thursday, 12/28/2023

Stocks that traded heavily or had substantial price changes on Thursday: Altice USA, PENN Entertainment rise; Hess, NeoGenomics fall

ABX.TO : 22.60 (+2.75%)
BABA : 72.46 (+1.22%)
AMZN : 180.14 (+0.17%)
HES : 151.99 (+0.96%)
ATUS : 2.62 (-0.19%)
AAPL : 171.71 (-0.92%)
NEO : 15.80 (+3.95%)
NeoGenomics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Utility of RaDaR for Therapy Response

FT. MYERS, FL / ACCESSWIRE / December 5, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading oncology testing services company, today announced new data highlighting its RaDaR® assay for minimal residual...

NEO : 15.80 (+3.95%)
NeoGenomics to Participate at the Piper Sandler 35th Annual Healthcare Conference

FT. MYERS, FL / ACCESSWIRE / November 14, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading oncology testing services company, today announced the company will participate in the upcoming Piper Sandler...

NEO : 15.80 (+3.95%)
NeoGenomics: Q3 Earnings Snapshot

NeoGenomics: Q3 Earnings Snapshot

NEO : 15.80 (+3.95%)
NeoGenomics Reports Third Quarter 2023 Results

Third Quarter Revenue Increased 18% to $152 Million

NEO : 15.80 (+3.95%)
NeoGenomics Announces the Commercial Availability of Two New Tests, Expanding Its Next-Generation Sequencing and Lung Cancer Portfolios

Neo Comprehensiveâ„¢ - Heme Cancers is a large and comprehensive next-generation sequencing panel with broad coverage of genes associated with blood cancers

NEO : 15.80 (+3.95%)
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

EQNX::TICKER_START (OTCQB:TDSGF),(TSXV:TELO),(NASDAQ:GH),(NASDAQ:NTRA),(NYSE:DGX),(NASDAQ:NEO) EQNX::TICKER_END

TDSGF : 0.0829 (+0.36%)
TELO.VN : 0.110 (-8.33%)
GH : 19.97 (+11.19%)
NTRA : 90.96 (+0.55%)
DGX : 133.11 (+1.56%)
NEO : 15.80 (+3.95%)

Barchart Exclusives

This Bausch Health Companies Unusually Active Option Is a No-Brainer
Bausch Health Companies had the 8th-highest Vol/OI ratio in Wednesday trading. The pharmaceutical company’s unusual options activity suggests it might have more gains ahead. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar